Announcing the appointment of our new Chief Medical Officer, Tom Lillie! Tom will be spearheading our clinical strategy & operations, and overseeing the clinical development of our pipeline. He brings extensive clinical leadership experience from over 20 years spent in pharma and biotech roles, and will be instrumental to Grey Wolf, as we continue to bring our innovative ERAP treatments to patients in need.

Read our announcement on LinkedIn